CoPPO 10th Anniversary Symposium – Bridging Genomic Research and Clinical Oncology
March 8th, 2024, the Phase 1 Unit and Department of Genomic Medicine, Rigshospitalet, will co-host a symposium celebrating 10 years with the Copenhagen Prospective Personalized Oncology study. The symposium will be bridging genomic research and clinical oncology.
The Copenhagen Prospective Personalized Oncology study (CoPPO) is a prospective, single-center, single-arm, open-label study conducted in the Phase 1 unit at Rigshospitalet. The primary objective of the study is to evaluate the clinical benefit of using molecular profiling of each patient’s tumor for selection of treatment in the phase 1 setting. In celebration of the 10-year-anniversary of the CoPPO study, we would like to invite all with an interest in personalized oncology to participate in the symposium.
Find the invitation and program below and register to join now. Participation is free of charge. Deadline for registration is February 28th.
We look forward to a day of sharing knowledge, networking, and celebration!
Best regards
Phase 1 Unit & Dept. of Genomic Medicine